Genetic loss of a single HLA allele has been proven to be associated with ICI resistance in MCC (76), as it results in an inability to effectively present tumor antigens, preventing CD8+ T cells from recognizing and killing tumor cells. This evidence concerns the gene CD8A and neoplasm.